Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Filed with BSE · · 2 pages · English
Summary by 6ix AI
The certificate confirms that all shares of the company are held in dematerialized form and that no requests for rematerialization were received during the reporting period. This filing serves to inform the BSE about the company's compliance status regarding shareholding.
Written by 6ix AI from the company’s filing. How 6ix writes summaries
Clinitech Laboratory Limited on 6ix
Earlier from Clinitech Laboratory
- Clinitech Laboratory Limited Press Release Sep 26 2026
- Clinitech Laboratory Limited Press Release Aug 24 2026
- Clinitech Laboratory Limited Press Release Aug 22 2026
- Clinitech Laboratory Limited Press Release Aug 17 2026
- Clinitech Laboratory Limited Press Release Aug 12 2026
Later from Clinitech Laboratory
- Non-Applicability Of Regulation 23 Of SEBI (LODR) Regulations, 2015 W.R.T Related Party Transactions
- Board Meeting Intimation for We Wish To Inform You That The Meeting Of The Board Of Directors Of The Company Will Be Held On Friday, November 13, 2026 Through Video Conferencing At 12.00 Noon (IST)
- Board Meeting Outcome for Outcome Of Board Meeting Held Today I.E On Friday, November 13, 2026 At 12.00 Noon (IST) Through Video Conferencing
- Unaudited Standalone & Consolidated Financial Results For The Half Year Ended September 30, 2026
- Statement Of Deviation Or Variation Under Regulation 32 Of SEBI (LODR) Regulations, 2015
Follow Clinitech Laboratory into a list and get an email when it puts out news.
Follow Clinitech Laboratory